Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma

Abstract

Abstract Objectives Salivary adenoid cystic carcinoma (SACC) is one of the most common salivary gland tumors in which patients encounter local recurrence and lung metastases. Understanding prognostic biomarkers in SACC is essential for future development in prognosis and treatment. This study aimed to assess the expression level of vascular endothelial growth factor (VEGF) and its potential regulatory microRNAs in SACC for prognostic determination. Material and Methods The expression of VEGF in SACC samples was assessed using immunohistochemistry. Potential regulatory microRNAs were evaluated using quantitative reverse transcription‐polymerase chain reaction. Associations between VEGF and microRNAs expression and clinicopathological parameters were investigated. Results VEGF expression levels positively correlated with histologic grade (p = .004) and treatment modality (p = .04). Decreased expression of miR‐29a (p = .01) and increased expression of miR‐93‐5p and miR‐205 (both p < .0001) were observed in SACC compared to normal salivary gland tissue. MiR‐93‐5p showed a positive association (p = .02) with VEGF overexpression. Conclusions Our results showed the downregulation of miR‐29 and overexpression of miR‐93 and miR‐205 in the SACC group, and the correlation between miR‐93 and VEGF suggests these biomarkers as potential prognostic markers in the future.

Keywords

• miR‐205
• miR‐29
• miR‐93
• salivary adenoid cystic carcinoma